Biodesix Inc (BDSX): Next-Year EPS Estimate 37.58%
As of 2026-09-10, Biodesix Inc (BDSX) has a next-year EPS growth estimate of 37.58%. Featured in our EPS revision report on 2026-06-29.
On 2026-08-11, analyst consensus for BDSX's next-year EPS growth shifted from 37.57% to 37.58% — a positive change of 0.01 percentage points. The revised estimate has been sustained across 28 subsequent trading sessions. Current-year growth is projected at 42.77%.
What's Driving This
The primary driver is the August 6 EPS estimate upgrade for next-year growth, climbing from 40.29% to 41.54%. This was supported by Biodesix's Q2 2026 earnings call, which reported a 34% revenue surge on strong diagnostic demand. The positive revision reflects that fundamental
Generated 2026-08-14 from news as of 2026-08-14
Current Snapshot
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- EPS growth next year
- 37.58%
- EPS growth this year
- 42.77%
- EPS next quarter (est)
- -$0.75
- Last price
- $26.04
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-10 | 37.58% | 42.77% | -$0.75 | $26.04 |
| 2026-09-09 | 37.58% | 42.77% | -$0.75 | $27.08 |
| 2026-09-08 | 37.58% | 42.77% | -$0.75 | $26.63 |
| 2026-09-07 | 37.58% | 42.77% | -$0.75 | $26.18 |
| 2026-09-06 | 37.58% | 42.77% | -$0.75 | $26.18 |
| 2026-09-04 | 37.58% | 42.77% | -$0.75 | $26.18 |
| 2026-09-03 | 37.58% | 42.77% | -$0.75 | $26.48 |
| 2026-09-02 | 37.58% | 42.77% | -$0.75 | $27.16 |
| 2026-09-01 | 37.58% | 42.77% | -$0.75 | $25.07 |
| 2026-08-31 | 37.58% | 42.77% | -$0.75 | $26.34 |
| 2026-08-30 | 37.58% | 42.77% | -$0.75 | $26.83 |
| 2026-08-29 | 37.58% | 42.77% | -$0.75 | $26.83 |
| 2026-08-28 | 37.58% | 42.77% | -$0.75 | $26.83 |
| 2026-08-27 | 37.58% | 42.77% | -$0.75 | $28.48 |
| 2026-08-26 | 37.58% | 42.77% | -$0.75 | $30.60 |
| 2026-08-25 | 37.58% | 42.77% | -$0.75 | $28.08 |
| 2026-08-24 | 37.58% | 42.77% | -$0.75 | $25.39 |
| 2026-08-23 | 37.58% | 42.77% | -$0.75 | $26.63 |
| 2026-08-21 | 37.58% | 42.77% | -$0.75 | $26.63 |
| 2026-08-20 | 37.58% | 42.77% | -$0.75 | $24.03 |
| 2026-08-19 | 37.58% | 42.77% | -$0.75 | $25.54 |
| 2026-08-18 | 37.58% | 42.77% | -$0.75 | $22.34 |
| 2026-08-17 | 37.58% | 42.77% | -$0.75 | $23.25 |
| 2026-08-16 | 37.58% | 42.77% | -$0.75 | $24.00 |
| 2026-08-14 | 37.58% | 42.77% | -$0.75 | $24.00 |
| 2026-08-13 | 37.58% | 42.77% | -$0.75 | $23.79 |
| 2026-08-12 | 37.58% | 42.77% | -$0.75 | $24.22 |
| 2026-08-11 | 37.58% | 42.77% | -$0.75 | $24.31 |
| 2026-08-10 | 37.57% | 42.77% | -$0.75 | $24.86 |
| 2026-08-09 | 38.28% | 42.00% | -$0.75 | $23.50 |
Reports Featuring BDSX
Recent News
Screen Performance
Aggregate stats across all 2034 tickers our top-EPS-revision screen has flagged over the past 162 days.
- Median return since detection
- +0.7%
- % of tickers in the green
- 51%
- Median return on winners
- +20.8%
- Large revisions captured
- 1697
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Biodesix Inc's next-year EPS growth estimate?▾
As of 2026-09-10, Biodesix Inc (BDSX) has a next-year EPS growth estimate of 37.58%, based on analyst consensus.
When was the latest EPS estimate revision for BDSX?▾
The most recent revision occurred on 2026-08-11, when analysts adjusted the next-year EPS growth estimate from 37.57% to 37.58%.
What sector and industry does Biodesix Inc belong to?▾
Biodesix Inc operates in the Healthcare sector, specifically the Diagnostics & Research industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BDSX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Biodesix Inc (BDSX) appears here because it was detected by our daily top-EPS-revision-performer screen.